Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
- Conditions
- Parkinson Disease
- Registration Number
- NCT00624741
- Lead Sponsor
- Bausch Health Americas, Inc.
- Brief Summary
This compassionate use study is designed to monitor safety in patients who have been doing well on pergolide therapy, wish to continue treatment, and have not been able to tolerate alternative treatments.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diagnosed with Parkinson's disease and treated successfully with pergolide in the recent past
- Attempt to taper off pergolide was unsuccessful and patient was unable to change to other forms of therapy for Parkinson's disease
- No evidence of cardiovalvular disease by echocardiogram conducted within 60 days prior
Exclusion Criteria
- History or current diagnosis of cardiac valvulopathy
- Inability to undergo echocardiograms every 6 months while receiving pergolide
- Hypersensitivity to pergolide or other ergot derivatives
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method